Prescribing Information
En Español
What do the Experts Say?
Tell A Friend
Find a pharmacy near you by entering your zip code
 

Dosing & Administration

Easy to dose and easy to take

Next Choice® is convenient for women to take.

Next Choice
The first tablet should be taken as soon as possible. The second tablet should be taken 12 hours later.

Note: Photos of tablets are larger than actual tablets.

There are simply 2 tablets:

  • The first should be taken within 72 hours of unprotected sex, sexual attack, or a known or suspected contraceptive failure.
  • The second should be taken 12 hours after the first tablet is taken

It is essential that Next Choice is taken as directed. The longer a woman waits to get started, the less effective they will be.3 You should let your patients know that Next Choice is most effective within the first 24 hours of having unprotected sex, sexual attack, or a known or suspected contraceptive failure. Counseling can help. By discussing emergency contraception with your patients prior to its necessity, your patients will be better prepared and have a clearer idea of their options. Discussion points have been provided for patient counseling. You may even consider providing an advance prescription to your patients – since timing is such a factor.

Important: If a patient vomits within 1 hour of taking Next Choice, you are the only one who should determine if a replacement dose is needed. Be sure to advise your patients to call you immediately if this or any other adverse event occurs.

Contraindications

Women should not take Next Choice if they have the following conditions:

  • Known or suspected pregnancy
  • Hypersensitivity to any component of the product

Important Safety Information

Next Choice® should not be used by women with a known or suspected pregnancy. Women who become pregnant or complain of lower abdominal pain after taking Next Choice should be evaluated for ectopic pregnancy. Next Choice is not effective in terminating an existing pregnancy, and does not protect against STI/HIV. Next Choice may alter the next expected menses, however, if menses is delayed beyond 1 week, pregnancy should be considered. The most common adverse reactions in the clinical trial were menstrual changes (26%), nausea (23%), abdominal pain (18%), fatigue (17%), headache (17%), dizziness (11%), and breast tenderness (11%).

To report side effects of prescription drugs to the FDA, visit fda.gov/medwatch or call 1-800-FDA-1088.

For more information about Next Choice, please call our Medical Communications Department at 866-9WATSON.

This Web site is intended for United States Prescribers, Pharmacists & Consumers.